Tred Avon Family Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$670K Buy
10,670
+2,155
+25% +$172K 0.22% 137
2025
Q4
$812K Buy
8,515
+4,161
+96% +$408K 0.26% 108
2025
Q3
$425K Buy
+4,354
New +$451K 0.15% 168

Other funds holding BSX

Tred Avon Family Wealth's BSX Position: Q1 2026 in Review

Tred Avon Family Wealth increased its Boston Scientific (BSX) stake by 25% in Q1 2026, buying an estimated $172K and bringing the position to 10,670 shares worth $670K. The position accounts for 0.22% of the portfolio, ranked #137.

Tred Avon Family Wealth first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $812K in Q4 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Tred Avon Family Wealth held 10,670 shares of Boston Scientific worth $670K as of Q1 2026.
  • Tred Avon Family Wealth bought 2,155 Boston Scientific shares in Q1 2026, an estimated $172K.
  • Boston Scientific made up 0.22% of Tred Avon Family Wealth's portfolio in Q1 2026, its #137 holding.
  • Tred Avon Family Wealth first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • Tred Avon Family Wealth's Boston Scientific position peaked at $812K in Q4 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Tred Avon Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.